Dogwood Therapeutics Inc. announced a salary adjustment for its Chief Financial Officer, Angela Walsh, as approved by the Board of Directors on June 27, 2025. Walsh's annual base salary will increase from $279,916 to $321,903, effective July 1, 2025. This decision followed a review of salary standards for similar roles within peer companies.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dogwood Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-009060), on July 02, 2025, and is solely responsible for the information contained therein.